We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Active Needle Technology offers an award-winning "needle actuating device" which has high value medical and consumer applications. The company's patent-pending proprietary ultrasonic technology enhances visibility for medical needles in applications such as biopsy, in regional and joint anaesthesia and others. The company aims to commercialise its technology into a $4+ billion special purpose needle market. After identifying obvious commercial advantages in the tattoo market, Active Needle plans to use its ultrasonic needle technology to develop a low-pain tattooing system. Moreover, the company has won an Innovate UK grant to develop and test the tattoo device. With the proceeds, the company will complete CE marking for its initial biopsy device, for development of anaesthesia and tattooing products.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £194,100
Emission Solutions (EMSOL) empowers organisations to take everyday steps to reduce emissions through their real-time emission monitoring and analytics system. EMSOL's open framework platform is built with networks of sensors like air and noise pollution, vehicle tracking, and working with any asset tags and emission sensors which enables EMSOL to perform real-time measurements with location tags and calibrated sensors. Data from these platforms are easily shared on dashboards, through notifications and gives detailed real-time data on urban noise, air quality, and vehicle pollution. To date, EMSOL won Rushlight Environmental Analysis Award, achieve yearly income targets, rated 5th place in the national PowerUp Index and 4th in the London and South East region. Moreover, EMSOL also won a fully funded project sponsored by DFT to deploy EMSOL technology into the rail sector. The company will use the funds to expand its customer base and increase the number of deployment sites.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £316,884
Over the past 8 years, Advatech Healthcare has created Hippo, a proven disabled and non-emergency patients transportation services (NEPTS) in the Essex area. Due to its dependability and efficiency, Hippo is now poised to become the UK's best national wheelchair accessible healthcare services on a wearable technology platform. According to the Office for Technology Statistics data, there are 13.37 million people disabled in the UK who lack dedicated non-emergency transportation. Hippo could save the National Health Service (NHS) up to 60% on transportation costs increasing faster hospital bed rotation and providing dedicated transportation for disabled and non-emergency patients with a medically trained staff. It also offers medical and technological necessities not offered by many leading operators. Currently, the company operates within the Essex area. By the end of 2020, the company aims to commence seven new contracts it has signed with the NHS. It also signed a deal with Cambridge Adult Social Care that is expected to close, within a 5-year term and generate over £200,000 per year.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
Innovate Recycle (IR) is a company that aims to reduce carbon emissions from burning discarded carpets. It asserts that only 2% of the 400,000 tonnes of discarded carpets in the UK is recycled, with the rest going into a landfill or being incinerated. IR further points out that burning waste carpet leads to an estimated CO2 impact of £16 million per annum in the UK. It wants to solve this crisis. IR is building a new carpet recycling plant in Northamptonshire that would be able to recycle carpets into reusable materials. They have already received grant funding of up to £2.35 million. IR claims that a single production line in the plant, at full capacity, can recycle up to 20,000 tonnes each year and generate 12,600 tonnes of polypropylene pellets. It will use the investment to expand to a second production line by Year 4 at the same facility.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £2,650,000
The Pension Lab offers an interative platform for employees and individuals, helping them reconnect and engage with their pensions. Its mission is to provide the customers with better knowledge of pensions and promote long-term financial decision making. The company has reached the finals of 'Pitchfest' competition held at the NEC as a component of “Venturefest”, and it is also a finalist in the “Innovation in Business” category. Some of the best Fintech solutions providers and pension services such as Yodlee and Origo are in partnership with the Pension Lab. With the proceeds, the company will develop its working capital, infrastructure development, and customer acquisition.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £38,024
Thyngs is a touch-free instant payment platform for businesses and charities. It has around 20 active re-seller partners for new sectors and markets. The company is working with PricewaterhouseCoopers (PwC) as part of its raise programme and actively engaging with several Series A Venture Capitalist (VC) funds intending to raise £4-5 million in late 2021 to scale its business. Thyngs aggregates various payment partners including PayPal, Worldpay, Apple Pay and Google Pay. The company was the cashless donation platform for 210,000 fundraising events for Macmillan's 'World's Biggest Coffee Morning', which raised £27 million in 2019. Many reputed organisations such as Warner Bros, Royal British Legion, Wasabi, National Geographic, and ANZ Bank are working with Thyngs. The company will use the investment to enhance its marketing campaign, bolster its sales team, work on data security and integrations on its platform, and expand the account management team to boost its business.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £329,591
Comino is an international start-up specialising in the design and production of liquid-cooled PCs and servers. It claims that its products consume up to 40% less electricity than equivalent air-cooling computers. The company currently operates in AI, Forensic, Gaming, and Video Rendering, with aspirations to enter other domains in the coming years. Comino has sold 2,000 work stations to professional businesses, accruing sales north of 9 million EUR since its launch in 2017. Its products have been accredited by global hardware giants like AMD and ASUS. The company will use 70% of proceeds for manufacturing its devices, 10% towards marketing and promotional materials, and 20% to compensate its teams.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £949,608
Evaclite manufactures dynamic exit signs designed to make buildings safer and save lives. The company argues that its products are 77% more visible than conventional exit signs and reduces congestion at exits by 36%. The company received the 2018 FIREX - Fire Innovation of the Year Award. It also won the Safety and Health Excellence (SHE) Award in 2019 and 2020. Evaclite counts companies like Apple, CBRE, BBC, Melia, and MetroBank amongst its clients. The company has inquiries from over a dozen countries globally with a 12-month sales opportunity pipeline of over £1.5 million. It will use 60% of the investment to build its sales team, 28% to boost its inbound marketing campaign, 7% to develop additional intellectual property, and 5% towards overhead and general costs.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £148,736
Luas Diagnostics (LD) aims to develop and market easy-to-use, rapid and accurate diagnostics tests with the aim of deploying these tests in remote settings away from centralised testing laboratories. The company has signed an exclusive distribution agreement with Chembio Diagnostics Systems (CDS) in the USA to market its Covid-19 antibody and antigen tests in the UK and Ireland. It has also signed a Memorandum of Understanding (MoU) with the University of Birmingham to develop saliva-based, rapid Covid-19 tests. LD is also working on coming up with a therapeutic drug monitoring system based on the same technology used worldwide to test people with diabetes for glucose levels in the blood. The company is developing the system so that it can be used at home, in pharmacies or GP surgery. The first product will test for Theophylline which is used to treat Chronic Obstructive Pulmonary Disease (COPD). LD will use the investment to grow its business across different verticals.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £326,190
Orbital Marine Power aims to harness the energy flowing in tidal streams and rivers through its award-winning tidal turbines. Orbital's O2 turbine is designed to deliver enough power for up to 2,000 homes. The company's vision is to focus on providing turbines and services into a future £20 billion per annum utility-scale global market for clean and predictable power from tidal streams. Orbital is currently providing £15 million of funded design projects to refine its IP protected low carbon tidal technology in readiness to scale up and play its part in meeting the ever-increasing demand for clean power. It will use the investment to grow its business across different verticals.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £2,595,231
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph